WAVE LIFE SCIENCES LTD. Liabilities, Noncurrent
WAVE LIFE SCIENCES LTD. (WVE) had Liabilities, Noncurrent of $53.99 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-07-30
- 2026-06-30: Liabilities, Noncurrent $53.99M.
- 2026-03-31: Liabilities, Noncurrent $21.98M.
- 2025-12-31: Liabilities, Noncurrent $17.20M.
- 2025-09-30: Liabilities, Noncurrent $23.06M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $53.99M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $21.98M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $17.20M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $23.06M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $17.81M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $21.30M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $23.86M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $38.26M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $31.29M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $36.13M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $41.01M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $132.55M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $133.60M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $161.54M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $112.08M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $113.90M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $110.42M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $101.05M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $102.43M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $131.10M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $129.97M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $133.27M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $67.55M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $84.28M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $90.11M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $90.96M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $94.49M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $91.15M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $93.36M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $94.00M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $84.68M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $84.30M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $162.79M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $16.20M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $16.17M 10-K · filed 2019-03-01 | $14.53M 10-K · filed 2018-03-12 |
| 2017-09-30 | $13.23M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $14.09M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $12.48M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $9.92M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $9.54M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $7.54M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $357.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $241.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $125.00K 10-Q · filed 2015-12-17 | |
| 2014-12-31 | $29.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |